These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9185392)

  • 1. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1997 Feb; 74(2):89-91. PubMed ID: 9185392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hepatitis C virus core antigenemia in Saudi drug users.
    Alzahrani AJ
    Saudi Med J; 2005 Oct; 26(10):1645-6. PubMed ID: 16228075
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
    Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
    Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing.
    Goldberg D; Cameron S; Sharp G; Burns S; Scott G; Molyneaux P; Scoular A; Downie A; Taylor A
    Int J STD AIDS; 2001 Jan; 12(1):17-21. PubMed ID: 11177477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus seroprevalence rate among Saudis.
    Shobokshi OA; Serebour FE; Al-Drees AZ; Mitwalli AH; Qahtani A; Skakni LI
    Saudi Med J; 2003 Jul; 24 Suppl 2():S81-6. PubMed ID: 12897907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus serology in parenteral drug users with chronic liver disease.
    Novick DM; Reagan KJ; Croxson TS; Gelb AM; Stenger RJ; Kreek MJ
    Addiction; 1997 Feb; 92(2):167-71. PubMed ID: 9158228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.